Ipilimumab (YERVOY?; Bristol-Myers Squibb, Princeton, NJ) is certainly a monoclonal antibody against cytotoxic T-lymphocyte antigen 4 (CTLA-4), which can be an immune system checkpoint regulator [3,32]
Ipilimumab (YERVOY?; Bristol-Myers Squibb, Princeton, NJ) is certainly a monoclonal antibody against cytotoxic T-lymphocyte antigen 4 (CTLA-4), which can be an immune system checkpoint regulator [3,32]. inside the outlined parts…